HUMA
Humacyte, Inc. · Healthcare
President, CEO and Director Laura E Niklason sold $6.6M of Humacyte, Inc.
Sold$6,606,799
$4.40Price
1,500,000Shares
−29%Stake
What HUMA did after the filing
- The stock from Wed, Nov 20 close, $4.41
- +12.0%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Jan 6 close.
Traded Mon, Nov 18. Filed Wed, Nov 20, 2:06 PM ET, during the session. Returns use the Nov 20 close and the Jan 6 close. Not investment advice.